What Makes Anavex Life Sciences (AVXL) One of the Best Shorted Penny Stocks [Yahoo! Finance]
Anavex Life Sciences Corp. (AVXL)
NASDAQ:AMEX Investor Relations:
anavex.com/share-data
Company Research
Source: Yahoo! Finance
More than 500% upside potential as of the April 23 close supports a highly bullish stance on the stock. Recent developments on the ongoing clinical trials also back the argument. On March 23, Anavex Life Sciences Corp. (NASDAQ:AVXL) released new data on blarcamesine at the AD/PD 2026 conference that was obtained during the ANAVEX2-73-AD-004 phase IIb/III clinical trial, which includes the extended access program, ANAVEX2-73-AD-EP-004. Billion Photos/Shutterstock.com It has been found through clinical data that patients possessing the SIGMAR1 and COL24A1 wild-type gene, belonging to the category of ABCLEAR32, derive greater benefit from blarcamesine treatment. Analysis of the MRI biomarkers showed an extremely strong correlation between decreased atrophy and benefits in both primary and secondary endpoints, such as cognitive performance, daily activities, and overall cognitive and functional improvements. When analyzing the genetic cohort ABCLEAR32 group of participants for prec
Show less
Read more
Impact Snapshot
Event Time:
AVXL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVXL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVXL alerts
High impacting Anavex Life Sciences Corp. news events
Weekly update
A roundup of the hottest topics
AVXL
News
- Anavex Life Sciences (AVXL) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (e+)" to "sell (d-)".MarketBeat
- Anavex Life Sciences Teases New Pivotal Blarcamesine Trials, Maps Regulatory Path at Needham Conference [Yahoo! Finance]Yahoo! Finance
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s DiseaseGlobeNewswire
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewswire
- Anavex Life Sciences (AVXL) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $24.00 price target on the stock.MarketBeat
AVXL
Earnings
- 2/9/26 - Beat
AVXL
Analyst Actions
- 2/10/26 - HC Wainwright
AVXL
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/25/26 - Form 8-K
- 2/25/26 - Form 8-K
- AVXL's page on the SEC website